Yoshiaki Furuyama

Before founding Tokyo Relife Clinic, I served as COO at Jiyugaoka Clinic—an internationally renowned aesthetic institution founded by Dr. Nobutaka Furuyama and built upon Kitasato University's pioneering plastic surgery team.

After witnessing countless patient transformations on the clinical frontlines, a fundamental question emerged:

"Does the pursuit of beauty ultimately reach its limit if we focus solely on the exterior?"

This question led me to Longevity Medicine. Dr. David A. Sinclair's declaration that "aging is a treatable condition" profoundly moved me, and I began studying under Professor Hidekazu Yamada, Japan's leading authority in anti-aging medicine.

True beauty radiates from within. To realize the ideals of longevity medicine, we must revitalize life at its very source: the cell. This conviction guided me to regenerative medicine and stem cell therapy.

However, through extensive research, I identified a critical flaw in the current regenerative medicine landscape: a severe lack of clinical data and transparent evidence. Very few clinics can scientifically answer the most fundamental question: "Does this actually work?"

Solving this demands seamless collaboration among academia, clinical practice, and cell processing centers. In 2023, with Professor Keisuke Goda of The University of Tokyo, we established an endowed research chair in cellular senescence regulation. Finally, on January 23, 2025, we officially launched Tokyo Relife Clinic, immediately initiating two major clinical studies involving 120 participants.

Investing heavily in clinical research during our startup phase drew criticism as being "reckless." Yet, I remain unwavering in our commitment to establishing scientific evidence. I firmly believe that accumulating robust clinical data is the most essential requirement for the global advancement of longevity and regenerative medicine. It is our fundamental responsibility and our sincere commitment to every patient.

Our daily dedication is bearing fruit. In October 2025, we partnered with The University of Tokyo's Goda Laboratory to compete in the global XPRIZE competition. I believe this is tangible proof that our science-first approach is gaining international academic recognition.

Our Mission is Clear:

To deliver cutting-edge laboratory discoveries to clinical practice as rapidly and safely as possible.

To provide evidence-based, world-class regenerative medicine that extends human healthspan and advances the field globally.

Beyond mere beauty lies a future of profound health and vitality. Though our current steps may be modest, our vision is vast. We advance with conviction—one patient, one breakthrough, one day at a time.